Е И Воронова
Biographic Data
| ID | 6814981 |
|---|---|
| NAME | Е И Воронова |
| GIVEN NAMES | Е И |
| FAMILY NAME | Воронова |
| SIGNATURE | ВОРОНОВА Е И |
| AFFILIATIONS | Sechenov University |
| ORCID | 0000-0001-6605-4851 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Early Clinical Effects of Novel Partial D3/D2 Agonist Cariprazine in Schizophrenia Patients With Predominantly Negative Symptoms (Open-Label, Non-controlled Study)
The results of this study suggest early effect of cariprazine on negative symptoms at least in some schizophrenia patients with predominantly negative symptoms starting from 1 to 2 weeks of treatment and could be useful for determination of early clinical predictors for efficacy. Considering limitations of open-label design with no control groups these data need to be confirmed
Stress-induced depression and reactive schizophrenia
A number of concepts exist which reveal an interaction between endogenous and psychogenic factors in stress-induced disorders in patients with schizophrenia. These concepts relate to psychological, pathophysiological, and sociological aspects of the problem. In this study we look at the respective states described within the clinical concept of reactive schizophrenia.Materials: Fifty clinical cases were included: 32 females and 18 males, mean age…
No prominent works on this page.
Stress-induced depression and reactive schizophrenia
A number of concepts exist which reveal an interaction between endogenous and psychogenic factors in stress-induced disorders in patients with schizophrenia. These concepts relate to psychological, pathophysiological, and sociological aspects of the problem. In this study we look at the respective states described within the clinical concept of reactive schizophrenia.Materials: Fifty clinical cases were included: 32 females and 18 males, mean age…
Early Clinical Effects of Novel Partial D3/D2 Agonist Cariprazine in Schizophrenia Patients With Predominantly Negative Symptoms (Open-Label, Non-controlled Study)
The results of this study suggest early effect of cariprazine on negative symptoms at least in some schizophrenia patients with predominantly negative symptoms starting from 1 to 2 weeks of treatment and could be useful for determination of early clinical predictors for efficacy. Considering limitations of open-label design with no control groups these data need to be confirmed
Medicine (2 works) · Psychiatry (2 works) · Psychology (2 works) · Psychosis (2 works) · Schizophrenia (object-oriented programming (2 works) · Adverse effect (1 work) · Agonist (1 work) · Akathisia (1 work) · Antipsychotic (1 work) · Clinical Psychology (1 work)